← Back to catalogue
Research draft

cytosine

vr.tr.cytosine · PHY.MAT

Enable an agent to identify cytosine, assess the form and quality of a particular sample, and determine its suitability for a proposed analytical, biochemical or material-handling task.

Thing Registry Physical world and living systems

Research draft, second pass

A second pass drafted this model: the structure a model of this thing needs, and what is known about it in the world. The line under this one says how the second half was obtained - researched against sources, or recalled without web access, in which case nothing here was read anywhere and every claim is a lead to verify. Unreviewed either way.

recalled by Codex without web access - no source was read

Researched by: Codex

Purpose and description

Enable an agent to identify cytosine, assess the form and quality of a particular sample, and determine its suitability for a proposed analytical, biochemical or material-handling task.

Cytosine is a pyrimidine nucleobase with molecular formula C4H5N3O that occurs in DNA and RNA as part of nucleotide residues and forms canonical Watson-Crick base pairs with guanine.

It can be Match a cytosine sample to a verified chemical identity and distinguish it from related bases or nucleosides.; Compare cytosine lots against the purity, water content and impurity requirements of a stated assay.; Calculate a solution preparation using the measured assay, material form and required concentration.; Select identification or quantification methods capable of separating cytosine from relevant impurities.; Investigate suspected conversion to uracil using analytical evidence and the sample's exposure history.; Determine whether documented storage and handling conditions support a proposed use..

Distinguishing features

Require a pyrimidine ring bearing an amino group at position 4 and an oxo group at position 2 in the conventional amino-oxo representation; a formula match alone does not establish cytosine identity.

Distinguish the free base from cytidine and deoxycytidine by the absence of a covalently attached sugar.

Distinguish cytosine from uracil by the amino-versus-oxo substitution at ring position 4; deamination changes the base identity.

Distinguish unmodified cytosine from 5-methylcytosine and other substituted analogues by explicitly checking ring substituents.

Treat complementary pairing with guanine as behaviour requiring a molecular context, rather than sufficient proof that an isolated substance is cytosine.

Scope

+ Molecular identity of the unmodified cytosine nucleobase, including distinctions among tautomeric and protonation states

+ Sample composition, purity, impurities, water content and isotopic composition

+ Solid-state and solution behaviour under explicitly recorded conditions

+ Transformations that alter cytosine identity or explain sample deterioration

+ Relations to cytidine, deoxycytidine, cytosine nucleotides and nucleic-acid residues

+ Evidence supporting identification, storage, handling and intended-use decisions

- Complete models of cytidine, deoxycytidine and their phosphorylated derivatives

- Complete models of modified bases such as 5-methylcytosine and 5-hydroxymethylcytosine

- DNA or RNA sequence, polymer architecture and whole-molecule function

- Cytosine biosynthesis pathways, enzyme systems and industrial manufacturing processes

- Finished formulations and mixtures containing cytosine

- Clinical interpretation of mutations, methylation patterns or drug responses

Characteristics

Molecular identity
C4H5N3O; structure representation with ring numbering and declared tautomer Separates cytosine from related bases and prevents identification from relying on a name or molecular formula alone.
Chemical identifier mapping
Verified CAS, PubChem and applicable jurisdictional identifiers, each linked to its source and represented chemical form Supports reliable matching of supplier records, analytical references and handling documentation.
Material presentation
Free-base solid, dissolved free base, or explicitly identified associated form Determines whether measurements and instructions apply to the actual material.
Assay and impurity profile
Mass fraction or molar fraction with method, uncertainty and reporting basis; chromatographic area percentage identified separately Controls dosing and suitability while preventing chromatographic purity from being mistaken for absolute content.
Water and residual solvent content
Mass fraction with analytical method and distinction between lattice-associated and adventitious water where established Affects weighed amounts, solid-state interpretation and comparison between lots.
Isotopic composition
Natural-abundance or labelled material; isotope, labelled position and enrichment when applicable Distinguishes ordinary reagent material from tracers and mass-spectrometric standards.
Solution concentration
mol/L or g/L with solvent composition, temperature, pH and preparation basis Makes solution preparation and assay exposure reproducible.
Protonation and tautomeric state
Assigned or unresolved state with medium, pH, temperature and supporting evidence Influences recognition, hydrogen bonding and interpretation of spectra or calculations.
Solubility and thermal behaviour
Solubility in g/L or mol/L; thermal events in °C with pressure, method and decomposition assessment Constrains preparation and processing without assuming that every reported thermal event is melting or boiling.
Nucleic-acid context
Free base or cytosine moiety linked to a separately identified nucleoside, nucleotide or polymer Prevents properties of bound cytosine from being assigned automatically to the isolated reagent.
Handling evidence status
Current applicable documentation, conflicting documentation, or evidence missing Makes handling decisions depend on the supplied form and documented conditions.

Also called

6-(¹⁵N)Amino(2,6-¹³C₂,¹⁵N₂)pyrimidin-2(1H)-one6-Amino(¹⁵N₂)pyrimidin-2(1H)-oneCytosine-5-t

Where this came from

wikidata · CC0 1.0

Drafted structure

Bundle to layer to finding to question, as the second pass will find it: 6 bundles · 11 layers · 16 findings · 26 questions.

Cytosine identity Establishes which molecular entity the name cytosine denotes and where its boundaries lie.

Free cytosine, its modified analogues and its sugar-linked derivatives must not share an undifferentiated identity.

Base structure

Records the structural features that establish the unmodified nucleobase.

Pyrimidine substitution

Identity assessment must resolve connectivity and substituent positions, including how tautomerism is represented.

  1. Does the verified structure establish the cytosine ring connectivity and amino-oxo substitution pattern? definition
  2. Which analytical or authoritative structural evidence supports the assigned identity and tautomer representation? provenance

Identity boundaries

Separates cytosine from related entities and reconciles identifiers.

Base versus derivative

Identifier matching must preserve distinctions between the free base, associated forms, sugar-linked derivatives and modified bases.

  1. Does this record describe free cytosine, an associated chemical form, or a cytosine moiety within another molecule? boundary
  2. Which verified identifiers refer to the exact represented form, and which refer to a neighbouring substance? provenance
Cytosine sample quality Connects the nominal substance identity to the actual contents and analytical quality of a sample.

A cytosine label alone cannot establish the amount of usable base or suitability for sensitive biochemical measurements.

Assay and contaminants

Resolves cytosine content and impurities relevant to the intended use.

Quantified base content

Content must have a stated reporting basis, with relevant related bases and residual materials assessed separately.

  1. What is the cytosine assay, and is it reported on an as-received, dry or other explicitly defined basis? measurement
  2. Can the method distinguish cytosine from uracil and other impurities relevant to this sample's origin or use? measurement

Water and isotopes

Records composition differences that can alter amount calculations or analytical interpretation.

Mass basis and labelling

Water, residual solvent and isotopic enrichment require explicit treatment when converting a weighed sample into an amount of cytosine.

  1. What water and residual solvent measurements are needed to calculate the amount of cytosine in the weighed material? measurement
  2. Is the material isotopically labelled, and what evidence establishes label positions and enrichment? provenance
Cytosine physical state Describes cytosine as a solid or dissolved base under specified conditions.

Solution preparation and thermal processing depend on the actual form and conditions of the material.

Solid and thermal behaviour

Connects solid-form evidence with observed thermal events.

Interpreted thermal events

Thermal records must distinguish phase transitions, water loss and decomposition rather than reduce them to an unqualified temperature.

  1. What evidence establishes the sample's solid form and any associated water? measurement
  2. Does a reported thermal event indicate melting, decomposition, water loss or an unresolved combination, and under what conditions? measurement

Dissolution and speciation

Relates achievable concentration to solvent conditions and molecular state.

Conditioned solution state

Solubility, concentration and protonation assignments need compatible solvent, temperature and pH records.

  1. What cytosine concentration is demonstrably dissolved in the specified solvent at the stated temperature and pH? measurement
  2. How do the chosen solution conditions affect the protonation or tautomeric assumptions used by the intended assay? action
Cytosine molecular relations Represents cytosine's biochemical context and transformations without taking ownership of entire biological systems.

Cytosine's recognition and transformation behaviour must be tied to whether it is free or incorporated into another molecule.

Bound-base context

Places cytosine within nucleosides, nucleotides and nucleic acids through explicit relations.

Contextual base recognition

Pairing and recognition statements require a specified host molecule and molecular environment.

  1. Is the behaviour being described observed for free cytosine or for its moiety within a named nucleoside, nucleotide or polymer? boundary
  2. What evidence and molecular context support a claimed interaction with guanine or another binding partner? provenance

Identity-changing reactions

Tracks transformations that consume cytosine or produce a separately identified base.

Deamination and modification

Conversion to uracil or a modified base must be recorded as a change of chemical identity, with conditions and evidence.

  1. What analytical evidence demonstrates conversion of cytosine to uracil or another identified product in this context? measurement
  2. Which exposure conditions or biological mechanisms are evidenced, and which remain hypotheses about the observed transformation? provenance
Cytosine use and handling Connects sample evidence to decisions about preparation, storage and permitted use.

Biological occurrence does not establish reagent suitability or replace documentation for the actual supplied material.

Fitness for assay

Evaluates whether a specific cytosine lot meets a defined analytical or biochemical task.

Task-specific acceptance

Acceptance depends on measured attributes and the intended method rather than an unexplained grade label.

  1. What limits on cytosine assay, uracil contamination, water content and other relevant impurities does the intended task require? action
  2. Does this lot have sufficient evidence for those limits, including any requirements for use as a calibration standard? provenance

Storage and documentation

Uses applicable supplier and jurisdictional evidence to govern handling of cytosine solids and solutions.

Documented handling conditions

Storage, hazard and disposal decisions require records applicable to the chemical form, concentration and jurisdiction.

  1. Which current safety document supports hazard classification and exposure controls for this supplied cytosine material? provenance
  2. What documented storage conditions and stability evidence justify retaining, retesting or discarding this solid or prepared solution? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

A model that cannot be lined up against existing standards, identifiers and practice cannot be adopted by anyone who already uses them.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  • This description is recalled knowledge; no sources were consulted.
  • Verify thermal decomposition, solubility and other physical constants against the specified solid form, purity and measurement conditions.
  • Check current supplier safety data and jurisdiction-specific records for hazard classification, regulatory identifiers and any applicable exposure limits.
  1. Which of these check these first hold for the sense of cytosine this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  • CAS Registry Number - 71-30-7 - Identifies cytosine as the free base.
  • PubChem CID - 597 - Compound identifier for cytosine.
  • Chemical nomenclature - 4-aminopyrimidin-2(1H)-one - Names the conventional amino-oxo tautomer.
  1. Which of these identifiers and schemes hold for the sense of cytosine this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  • Starting material for synthesis of nucleosides, nucleotides and related compounds.
  • Reference material in analytical methods that distinguish nucleic-acid bases.
  • Research on base pairing, tautomerism and nucleic-acid chemistry.
  1. Which of these real-world use hold for the sense of cytosine this model covers, and on what evidence? provenance

Typical measurements

Recalled without web access and unsourced; every item is a lead to verify.

  • Molar mass - 111.10 - g/mol
  • Hydrogen bonds in a canonical cytosine-guanine base pair - 3 - hydrogen bonds per base pair
  1. Which of these typical measurements hold for the sense of cytosine this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  • Hydrolytic deamination converts cytosine to uracil; in DNA, an unrepaired lesion can lead to a C:G-to-T:A transition mutation.
  • Rare tautomeric or protonation states can alter base-pairing specificity.
  • Water content and chemical impurities can affect weighed concentrations and analytical results.
  1. Which of these failure modes and hazards hold for the sense of cytosine this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  • cytidine - Cytidine is cytosine attached to ribose; cytosine alone has no sugar.
  • deoxycytidine - Deoxycytidine is cytosine attached to 2-deoxyribose.
  • cytidine monophosphate - This nucleotide contains cytosine, ribose and a phosphate group.
  • uracil - Uracil has a carbonyl group at position 4 where cytosine has an amino group.
  • 5-methylcytosine - 5-Methylcytosine carries an additional methyl group at ring position 5.
  • guanine - Guanine is a purine with two fused rings and is cytosine's canonical pairing partner.
  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of cytosine this model covers, and on what evidence? provenance

What the second pass must settle

  • Which authoritative sources establish the CAS number, PubChem CID and applicable EC identity for the exact cytosine form represented?
  • Which reported solubility and acid-base constants are sufficiently conditioned by solvent, temperature and measurement method to support preparation decisions?
  • Which solid forms are established, and do reported high-temperature values describe melting, decomposition or overlapping events rather than a usable boiling point?
  • What current hazard classifications and substance-specific or general exposure limits apply in the intended jurisdiction and to the supplied material?
  • What evidence supports storage lifetimes and acceptable uracil or other impurity limits for the intended cytosine reagent and solution uses?